Ident. | Authors (with country if any) | Title |
---|
000103 (2011) |
Yoichiro Kikuchi [Japon] ; Takao Yasuhara [Japon] ; Takashi Agari [Japon] ; Akihiko Kondo [Japon] ; Satoshi Kuramoto [Japon] ; Masahiro Kameda [Japon] ; Tomohito Kadota [Japon] ; Tanefumi Baba [Japon] ; Naoki Tajiri [Japon] ; Feifei Wang [Japon] ; Judith T. Tayra [Japon] ; Hanbai Liang [Japon] ; Yasuyuki Miyoshi [Japon] ; Cesario V. Borlongan [États-Unis] ; Isao Date [Japon] | Urinary 8‐OHdG elevations in a partial lesion rat model of parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion |
000115 (2011) |
James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada] | The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease |
000143 (2011) |
René Hernández- Vargas [Mexique] ; Luis Fonseca- Ornelas [Mexique] ; Ignacio L Pez- González [Mexique] ; Juan Riesgo- Escovar [Mexique] ; Mario Zurita [Mexique] ; Enrique Reynaud [Mexique] | Synphilin suppresses α‐synuclein neurotoxicity in a Parkinson's disease Drosophila model |
000159 (2011) |
Keisuke Matsubara [Japon] ; Hiroshi Watabe [Japon] ; Yoshitaka Kumakura [Japon] ; Takuya Hayashi [Japon] ; Christopher J. Endres [États-Unis] ; Kotaro Minato [Japon] ; Hidehiro Iida [Japon] | Sensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: A simulation study for [18F]FDOPA PET by a model with detailed dopamine pathway |
000229 (2011) |
Yuen-Sum Lau [États-Unis] ; Gaurav Patki [États-Unis] ; Kaberi Das-Panja [États-Unis] ; Wei-Dong Le [États-Unis] ; S. Omar Ahmad [États-Unis] | Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration |
000230 (2011) |
Lucia Frau [Italie] ; Franco Borsini [Italie] ; Jadwiga Wardas [Pologne] ; Amit S. Khairnar [Italie] ; Nicoletta Schintu [Italie] ; Micaela Morelli [Italie] | Neuroprotective and anti‐inflammatory effects of the adenosine A2A receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease |
000276 (2011) |
Lazlo Horvath [Suède] ; Ingrid Van Marion [Suède] ; Khalid Taï [Suède] ; Troels Tolstrup Nielsen [Danemark] ; Cecilia Lundberg [Suède] | Knockdown of GAD67 protein levels normalizes neuronal activity in a rat model of Parkinson's disease |
000289 (2011) |
Guadalupe Soria [Espagne] ; Esther Aguilar [Espagne] ; Raúl Tudela [Espagne] ; Joaquim Mullol [Espagne] ; Anna M. Planas [Espagne] ; Concepci Marin [Espagne] | In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson’s disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese‐enhanced magnetic resonance imaging in the 6‐hydroxydopamine rat model |
000702 (2010) |
Aleksandra Glavaski-Joksimovic [États-Unis] ; Tamas Virag [États-Unis] ; Thomas A. Mangatu [États-Unis] ; Michael Mcgrogan [États-Unis] ; Xue Song Wang [États-Unis] ; Martha C. Bohn [États-Unis] | Glial cell line‐derived neurotrophic factor–secreting genetically modified human bone marrow‐derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease |
000724 (2010) |
Marta G. Vu Ckovi [États-Unis] ; Quanzheng Li [États-Unis] ; Beth Fisher [États-Unis] ; Angelo Nacca [États-Unis] ; Richard M. Leahy [États-Unis] ; John P. Walsh [États-Unis] ; Jogesh Mukherjee [États-Unis] ; Celia Williams [États-Unis] ; Michael W. Jakowec [États-Unis] ; Giselle M. Petzinger [États-Unis] | Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: In vivo imaging with [18F]fallypride |
000728 (2010) |
Wei-Bin Shen [États-Unis] ; Kimberly A. Mcdowell [États-Unis] ; Aubrey A. Siebert [États-Unis] ; Sarah M. Clark [États-Unis] ; Natalie V. Dugger [États-Unis] ; Kimberly M. Valentino [États-Unis] ; H. A. Jinnah [États-Unis] ; Carole Sztalryd [États-Unis] ; Paul S. Fishman [États-Unis] ; Christopher A. Shaw [Canada] ; M. Samir Jafri [États-Unis] ; Paul J. Yarowsky [États-Unis] | Environmental neurotoxin‐induced progressive model of parkinsonism in rats |
000912 (2009) |
David A. Price [États-Unis] ; Alex A. Martinez [États-Unis] ; Alexandre Seillier [États-Unis] ; Wouter Koek [États-Unis] ; Yolanda Acosta [États-Unis] ; Elizabeth Fernandez [États-Unis] ; Randy Strong [États-Unis] ; Beat Lutz [Allemagne] ; Giovanni Marsicano [France] ; James L. Roberts [États-Unis] ; Andrea Giuffrida [États-Unis] | WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease |
000951 (2009) |
Michaela Hahn [Allemagne] ; Marco Timmer [Allemagne] ; Guido Nikkhah [Allemagne] | Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease |
000965 (2009) |
Xin Yang [Belgique] ; Birgit Mertens [Belgique] ; Enni Lehtonen [Belgique] ; Linda Vercammen [Belgique] ; Olivier Bockstael [Belgique] ; Abdelwahed Chtarto [Belgique] ; Marc Levivier [Belgique, Suisse] ; Jacques Brotchi [Belgique] ; Yvette Michotte [Belgique] ; Veerle Baekelandt [Belgique] ; Sophie Sarre [Belgique] ; Liliane Tenenbaum [Belgique] | Reversible neurochemical changes mediated by delayed intrastriatal glial cell line‐derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model |
000995 (2009) |
Gero Falkenstein [Allemagne] ; Christoph Rosenthal [Allemagne] ; Torsten Reum [Allemagne] ; Rudolf Morgenstern [Allemagne] ; Máté Döbrössy [Allemagne] ; Guido Nikkhah [Allemagne] | Pattern of long‐term sensorimotor recovery following intrastriatal and ‐accumbens DA micrografts in a rat model of Parkinson's disease |
000A22 (2009) |
Shin-Ichi Muramatsu [Japon] ; Tsuyoshi Okuno [Japon] ; Yutaka Suzuki [Japon] ; Takashi Nakayama [Japon] ; Takeharu Kakiuchi [Japon] ; Naomi Takino [Japon] ; Asako Iida [Japon] ; Fumiko Ono [Japon] ; Keiji Terao [Japon] ; Nobuo Inoue [Japon] ; Imaharu Nakano [Japon] ; Yasushi Kondo [Japon] ; Hideo Tsukada [Japon] | Multitracer assessment of dopamine function after transplantation of embryonic stem cell‐derived neural stem cells in a primate model of Parkinson's disease |
000A73 (2009) |
Na K. Kim [Corée du Sud] ; Byung H. Choi [Corée du Sud] ; Xian Huang [Corée du Sud] ; Brian J. Snyder [Canada] ; Shefqat Bukhari [Canada] ; Tae-Ho Kong [Corée du Sud] ; Hyeonseon Park [Corée du Sud] ; Hyung C. Park [Corée du Sud] ; So R. Park [Corée du Sud] ; Yoon Ha [Corée du Sud] | Granulocyte–macrophage colony‐stimulating factor promotes survival of dopaminergic neurons in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced murine Parkinson’s disease model |
000B15 (2009) |
Nadja Van Camp [Belgique, France] ; Ines Blockx [Belgique] ; Marleen Verhoye [Belgique] ; Cindy Casteels [Belgique] ; Frea Coun [Belgique] ; Alexander Leemans [Royaume-Uni, Pays-Bas] ; Jan Sijbers [Belgique] ; Veerle Baekelandt [Belgique] ; Koen Van Laere [Belgique] ; Annemie Van Der Linden [Belgique] | Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract |
000B20 (2009) |
Adam Zaidel [Israël] ; Alexander Spivak [Israël] ; Lavi Shpigelman [Israël] ; Hagai Bergman [Israël] ; Zvi Israel [Israël] | Delimiting subterritories of the human subthalamic nucleus by means of microelectrode recordings and a Hidden Markov Model |
000D81 (2008) |
Haiqun Jia [République populaire de Chine] ; Xin Li [République populaire de Chine] ; Hongxiang Gao [République populaire de Chine] ; Zhihui Feng [République populaire de Chine] ; Xuesen Li [République populaire de Chine] ; Lei Zhao [République populaire de Chine] ; Xu Jia [République populaire de Chine] ; Hongyu Zhang [République populaire de Chine] ; Jiankang Liu [États-Unis] | High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson's disease |
000E15 (2008) |
Masaki Wakamatsu [Japon] ; Shingo Iwata [Japon] ; Takeo Funakoshi [Japon] ; Makoto Yoshimoto [Japon] | Dopamine receptor agonists reverse behavioral abnormalities of α‐synuclein transgenic mouse, a new model of Parkinson's disease |